Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nuvectis Pharma Inc shares valued at $28,600 were purchased by BENTSUR RON on Nov 05 ’25. At $5.72 per share, BENTSUR RON acquired 5,000 shares. The insider’s holdings grew to 3,525,924 shares worth approximately $26.62 million following the completion of this transaction.
Also, Sanchez Juan purchased 13,000 shares, netting a total of over 75,270 in proceeds. Following the buying of shares at $5.79 each, the insider now holds 78,150 shares.
Before that, Kaplan Matthew L. had added 11,000 shares to its account. In a trade valued at $64,240, the Director bought Nuvectis Pharma Inc shares for $5.84 each. Upon closing the transaction, the insider’s holdings increased to 11,000 shares, worth approximately $0.94 million.
As published in their initiating research note from Maxim Group on April 02, 2025, Nuvectis Pharma Inc [NVCT] has been a Buy and the price target has been revised to $17. Analysts at Laidlaw started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of July 13, 2022, Ladenburg Thalmann has initiated its “Buy” rating for NVCT.
Analyzing NVCT Stock Performance
On last trading session, Nuvectis Pharma Inc [NASDAQ: NVCT] rose 2.30% to $7.55. The stock’s lowest price that day was $7.22, but it reached a high of $7.67 in the same session. During the last five days, there has been a drop of approximately -1.69%. Over the course of the year, Nuvectis Pharma Inc shares have jumped approximately 44.64%. Shares of the company reached a 52-week high of $11.52 on 04/28/25 and a 52-week low of $5.33 on 01/02/25.
Support And Resistance Levels for Nuvectis Pharma Inc (NVCT)
According to the 24-hour chart, there is a support level at 7.29, which, if violated, would cause prices to drop to 7.03. In the upper region, resistance lies at 7.74. The next price resistance is at 7.93. RSI (Relative Strength Index) is 56.53 on the 14-day chart, showing neutral technical sentiment.
Is Nuvectis Pharma Inc subject to short interest?
Stocks of Nuvectis Pharma Inc saw a sharp rise in short interest on 2025-12-15 jumping by 0.1 million shares to 1.43 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 1.33 million shares. A jump of 7.29% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 15.14 of the overall float, the days-to-cover ratio (short ratio) jumped to 15.14.
Which companies own the most shares of Nuvectis Pharma Inc (NVCT)?
In terms of Nuvectis Pharma Inc share price expectations, FactSet research, analysts set an average price target of 10 in the next 12 months, up nearly 35.5% from the previous closing price of $7.38. Analysts anticipate Nuvectis Pharma Inc stock to reach 10 by 2026, with the lowest price target being 10.
